查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864432

安氟醚市场：2025-2032年全球预测（按最终用户、应用、产品类型和分销管道划分）

Enflurane Market by End User, Application, Product Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，安氟醚市场规模将成长至 3.1238 亿美元，复合年增长率为 4.73%。

关键市场统计数据
基准年 2024 2.157亿美元
预计年份：2025年 2.2614亿美元
预测年份 2032 3.1238亿美元
复合年增长率 (%) 4.73%

基于实证医学的恩氟烷应用：涵盖药理学、临床考虑、监管进展及其对现代麻醉护理的背景影响

恩氟烷在麻醉药理学中仍然是一种具有历史意义和临床价值的分子，以其中枢神经系统抑制特性和独特的血液动力学特征而闻名。儘管在许多情况下，新型挥发性麻醉剂已经取代了恩氟烷，但其独特的药理特性和已确立的临床数据仍然影响着临床实践模式、监管讨论和库存决策。本文认为，恩氟烷并非过时的药物，而是一种其当代价值受到不断发展的安全性证据、供应链趋势和不同地区监管态度影响的化合物。

要了解安氟醚在现代麻醉领域的应用，需要考虑临床效用和风险管理之间的相互作用。产业相关人员必须权衡安氟醚已知的麻醉效果与一些潜在风险，例如高浓度下可能引发癫痫发作以及代谢物经肾臟清除等。此外，对环境永续性的日益重视正在影响吸入麻醉领域，促使人们重新关注麻醉剂的选择和清除技术。因此，要实现精细化的应用，需要关注药理学、临床医生的偏好、机构通讯协定以及其他更广泛的因素，这些因素将决定安氟醚是继续作为麻醉剂库中的主力军，还是仅限于特定用途。

临床监测技术的进步、监管的加强、供应链的现代化以及对永续性的重视等变革性因素正在重塑安氟醚在医疗保健领域的使用。

安氟醚的当代应用轨迹受到多种变革性因素的影响，远非简单的挥发性麻醉剂选择所致。手术全期监测和麻醉输送系统的进步使临床医生能够更精确地控制麻醉深度和生理稳定性，从而减少了对主要基于血流动力学特征选择的麻醉剂的依赖。同时，监管力度的加强和临床指南的更新也改变了许多医疗中心的风险承受阈值，促使他们重新评估具有显着神经生理特性的化合物。

此外，供应链的现代化和多元化正在影响医院和诊所传统药物的供应。随着整合医疗系统将供应的连续性和成本可预测性置于优先地位，筹资策略越来越多地采用供应商冗余和长期合约。同时，永续性的迫切需求正在重塑产品评估框架。吸入麻醉剂的生命週期评估以及回收和销毁技术的进步，奖励将环境影响作为处方决策的关键因素。这些趋势共同作用，使得安氟醚的角色从一种广泛使用的麻醉剂转变为一种在临床路径中经过精心管理的药物，其风险效益比仍然有利。

2025年美国关税对恩氟烷供应连续性、采购行为、定价策略和相关人员分销韧性的累积影响

美国2025年生效的关税政策已在整个药品供应链中造成了显着的摩擦，恩氟烷也未能倖免。这些关税不仅影响了药品的单价结构，也影响了筹资策略、合约关係和库存管理政策。为此，许多下游相关人员正在重新审视供应商多元化和近岸外包方案，以降低关税风险和采购週期波动的影响。这些调整也正在改变供应商对麻醉剂库存深度和前置作业时间缓衝的处理方式。

除了采购之外，关税政策的变化也促使製造商和经销商重新评估其定价策略和分销网络。一些生产商正在考虑重组其生产物流以保持竞争力，而另一些生产商则在调整与中间经销商的合约条款以保障利润率。对于临床医生和医院供应链管理人员而言，这些变化凸显了事先规划的重要性。处方委员会越来越重视供应商的韧性，并将其作为核心标准，促使他们采取更严格的库存管理措施，以确保临床护理点的持续供应。最终，2025 年关税环境的累积影响将是增强供应端的韧性，并更加重视策略采购，这将直接影响安氟醚的供应和医院的准备情况。

进行全面的細項分析以明确需求驱动因素：整合终端用户画像、手术应用需求、产品类型差异和分销管道趋势

透过既定的细分观点分析安氟醚，可以深入了解其需求和营运考量。每个观点都揭示了不同的驱动因素和限制因素。从最终使用者的角度来看，由于手术量、人员配置模式和药物清单管理方面的差异，门诊手术中心、诊所和医院在麻醉剂偏好上有所不同。门诊机构往往优先考虑快速恢復和高效率，而诊所可能更重视小型手术的成本效益通讯协定。同时，医院必须在应对各种复杂程度的手术的同时，兼顾自身的风险管理政策。

在心血管外科、一般外科、神经外科和整形外科等不同适应症中，驱动药物选择的临床需求差异显着。心血管外科需要严格的血流动力学管理和多学科协作；神经外科对脑生理和癫痫阈值提出了独特的关注；整形外科通常侧重于多模式镇痛和疗效；而普通外科涵盖广泛的临床频谱，因此灵活的麻醉策略至关重要。产品类型的差异进一步增加了决策的复杂性。品牌药和非专利药的存在会影响采购谈判、互换性认知以及监管文件。同时，对生产品质和供应可靠性的认知也会影响对某种产品类型的偏好。分销管道的趋势影响药物的可及性和可获得性。直销关係支援大型医疗系统客製化的服务模式；包括B2B入口网站和电子商务平台在内的线上管道能够扩大商业性覆盖范围；零售药局通路（主要是连锁药局和独立药局）影响门诊病人的用药；而批发分销仍是大规模补货的基础。这些环节之间的相互作用决定了安氟醚输送的实际操作情况以及它可能被使用的临床情况。

高解析度区域分析比较了美洲、欧洲、中东和非洲以及亚太地区在临床应用、供应弹性和法规环境方面的差异。

区域趋势对安氟醚的临床相关性、供应和法规环境起着至关重要的作用，各大区域呈现出不同的模式。在美洲，机构采购惯例、报销框架以及大型综合医疗系统的集中化往往导致标准化的处方笺管理和集中式合同，这影响着医院库存中麻醉剂的种类以及在供应中断时替代采购方案的实施速度。该地区的法律规范在于上市后监测和临床医生安全，这影响着安氟醚的选择。

欧洲、中东和非洲地区呈现出多元化的格局，各国之间以及各国内部在管理体制、医疗基础设施成熟度和采购实践方面存在显着差异。虽然强有力的环境和永续性要求对西欧部分地区的麻醉剂政策产生了重大影响，但在中东和北非地区，药品可近性和供应链韧性仍然是关键的营运问题。最后，亚太地区的趋势反映了医疗服务能力的快速成长、公私服务模式的多元化以及对生产和供应链在地化的策略性投资。该地区在临床实务规范和监管进展速度方面也存在差异，这些因素共同影响安氟醚在各医疗机构的评估、应用和分配方式。

对恩氟烷相关人员进行公司层面的竞争考察，重点在于供应策略、产品系列优化、品质透明度和临床医师参与方式。

与安氟醚相关企业在竞争格局上涵盖了成熟的生产商、专业製药公司、经销商和临床服务提供者。一些企业专注于精简产品系列併提高营运效率，以确保传统麻醉剂的持续供应；而另一些企业则优先投资于监管合规和品管，以支援与医疗系统签订的长期合约。各企业策略上的差异显而易见：有些企业正在垂直整合生产和分销环节，以降低中间环节中断的风险；而另一些企业则在建立多元化的供应商网络，以增强自身韧性。

该领域的创新工作往往侧重于配方一致性、改进包装以提高操作性和剂量准确性，以及与医疗设备製造商合作以提高剂量和回收效率。此外，积极透过实证医学传播、培训计画和处方集支持等方式与临床医生互动的公司，其产品更容易获得机构认可，并建立长期合作关係。在整个价值链中，生产来源的透明度、批次级可追溯性以及对品质问题的快速反应正成为影响采购决策的关键因素，尤其对于大型医院系统和采购联盟而言更是如此。

为製造商、经销商和医疗保健提供者提供切实可行的建议，以增强供应链韧性、吸引临床医生参与、融入永续性并优化分销策略。

产业领导者若想在不断变化的安氟醚市场中有效定位自身，应采取一系列切实可行的措施，协调商业性、临床和营运方面的优先事项。首先，应优先考虑供应商的韧性，透过多元化采购管道和协商合约机制，确保能够灵活调整供应量以应对需求波动。其次，应积极与临床相关人员互动，资助有针对性的教育和证据审查，以阐明安氟醚在特定外科适应症中的比较优势和风险管理通讯协定。这些临床医生的措施将有助于建立信任，并促进有关处方集的建设性讨论。

第三，我们将建构兼顾环境影响的产品价值提案，具体做法是记录产品生命週期的环境影响，并在适用情况下支持回收和废弃物处理技术的投资。第四，我们将加强品管和可追溯性能力。生产资料和批次级文件的透明化将减少采购摩擦，并有助于符合监管要求。第五，我们将重新评估分销策略，将直接销售给关键客户与强大的线上和批发伙伴关係相结合，旨在确保在各种医疗机构中都能获得产品。最后，我们将保持积极的监管沟通，预测政策变化并参与指南制定，从而影响决策者对安氟醚的评估标准。

这项关于恩氟烷的分析以稳健的调查方法为基础，该方法说明了证据三角测量、专家检验、定性综合和基于情境的压力测试。

本分析采用系统性的调查方法，整合了多方面的证据，强调资讯来源三角验证、专家检验和情境解读。主要资料来源包括同侪审查的临床文献、监管指导文件以及从采购从业人员和生产相关人员收集的匿名供应链资讯。次要资料来源包括白皮书、麻醉剂给药和清除方面的技术指南，以及已在其处方集决策过程中评估过安氟醚的机构提供的营运案例研究。

为确保研究结果的稳健性，我们将对临床医生和供应链管理人员的访谈定性结果与监管文件和生产品质资讯进行了交叉比对。分析程序包括对定性资料进行主题编码、建立情境图以探索政策和采购变更的影响，以及根据已记录的关税和物流变更对供应链假设进行压力测试。研究结果由麻醉师、药剂师和采购负责人组成的专家评审小组进行检验，以确认其实际意义并完善建议。在整个过程中，我们始终保持假设和证据来源的透明性，以确保研究结果的可重复性，并便于在报告后的咨询服务中为客户提供客製化服务。

对製造商、医疗保健提供者和政策制定者而言，本报告旨在全面综合战略意义，以确保在安氟醚相关决策中，能够做出合理、以患者为中心且具有营运韧性的决策。

总之，安氟醚在现代麻醉护理中占据着微妙的地位。儘管在许多情况下其常规使用有所减少，但当其特定的药理特性与临床需求相符时，它仍然效用。监管的关注、永续性问题以及供应链压力共同促使人们重新定义麻醉剂处方清单的选择和维持标准。因此，相关人员必须权衡临床疗效与供应稳定性、环境影响和组织风险接受度等因素。

展望未来，供应商多元化、临床医生参与和透明的品管等策略性倡议将决定安氟醚在手术全期护理中的地位。政策制定者和机构领导者应优先考虑以实证医学为基础的指南制定和采购政策，并将营运实际情况和环境因素纳入考量。透过协调临床通讯协定、筹资策略以及与监管机构的对话，相关人员可以确保有关安氟醚的决策具有合理性、以患者为中心且在营运上永续。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 一系列监管审查评估了氟烷排放对环境的影响
  • 人们对专为资源匮乏的手术中心订製的安氟醚製剂越来越感兴趣
  • 引进一种新型闭路麻醉剂输送系统以减少安氟醚的消费量
  • 非专利药生产商与OEM供应商建立新的合作伙伴关係，旨在扩大安氟醚在亚洲的供应。
  • 门诊癌症患者镇静和疼痛管理通讯协定中安氟醚应用的临床调查
  • 替代性氟化麻醉剂日益激烈的价格竞争对安氟醚在欧洲的市占率构成挑战。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依最终用户分類的安氟醚市场

  • 门诊手术中心
  • 诊所
  • 医院

第九章安氟醚市场应用

  • 心血管外科
  • 一般外科
  • 神经外科
  • 整形外科手术

第十章 安氟醚市场（依产品类型划分）

  • 品牌产品
  • 非专利的

第十一章安氟醚市场（按分销管道）

  • 直销
  • 在线的
    • B2B入口网站
    • 电子商务平台
  • 零售药房
    • 连锁药局
    • 独立药房
  • 批发的

第十二章 各地区安氟醚市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 安氟醚市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国安氟醚市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • Piramal Enterprises Limited
    • Hikma Pharmaceuticals PLC
    • Baxter International Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sandoz International GmbH
    • Viatris Inc.
    • Hetero Labs Limited
Product Code: MRR-F97DD5A7D999

The Enflurane Market is projected to grow by USD 312.38 million at a CAGR of 4.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 215.70 million
Estimated Year [2025] USD 226.14 million
Forecast Year [2032] USD 312.38 million
CAGR (%) 4.73%

An evidence-based introduction to enflurane covering pharmacology, clinical considerations, regulatory dynamics, and contextual relevance for contemporary anesthesia practice

Enflurane remains a molecule of historical and clinical interest within the anesthetic pharmacopeia, recognized for its central nervous system depressant properties and particular hemodynamic profile. Although newer volatile agents have eclipsed enflurane in many settings, its unique pharmacologic characteristics and established clinical data continue to inform practice patterns, regulatory conversations, and inventory decisions. This introduction frames enflurane not as a relic but as a compound whose present-day relevance is shaped by evolving safety evidence, supply chain dynamics, and divergent regional regulatory postures.

To understand enflurane's contemporary footprint, it is essential to consider the interplay of clinical utility and risk management. Industry stakeholders must weigh enflurane's known anesthetic effects against concerns such as seizure risk at high concentrations and renal handling of its metabolites. Moreover, the landscape of inhalational anesthesia has been influenced by growing emphasis on environmental sustainability, which has redirected attention to agent selection and scavenging technology. Consequently, a nuanced introduction requires attention to pharmacology, clinician preference, institutional protocols, and the broader forces that determine whether enflurane remains an active component of anesthetic formularies or is relegated to specialized roles.

Transformative forces including clinical monitoring advances, regulatory tightening, supply chain modernization, and sustainability priorities reshaping enflurane utilization across care settings

The contemporary trajectory of enflurane utilization is being shaped by multiple transformative shifts that go beyond simple preferences for one volatile agent over another. Advances in perioperative monitoring and anesthesia delivery systems have enabled clinicians to target anesthetic depth and physiological stability with greater precision, reducing reliance on agents selected primarily for their hemodynamic profiles. Simultaneously, heightened regulatory scrutiny and updated clinical guidance have altered risk tolerance thresholds in many institutions, prompting a reevaluation of compounds with distinct neurophysiologic signatures.

Furthermore, supply chain modernization and procurement diversification are influencing how hospitals and clinics maintain access to legacy agents. As integrated healthcare systems prioritize supply continuity and cost predictability, purchasing strategies increasingly incorporate supplier redundancy and longer-term contracting. In parallel, sustainability imperatives are reframing product evaluation; life-cycle assessments of inhalational agents and advances in scavenging and destruction technologies have created incentives to consider environmental impact as a material input in formulary decision-making. Taken together, these trends are catalyzing a shift in enflurane's role from a broadly available anesthetic to a component whose use is deliberately managed within clinical pathways where its risk-benefit calculus remains favorable.

Cumulative implications of the 2025 United States tariff measures on enflurane supply continuity, procurement behaviors, pricing strategies, and distribution resilience across stakeholders

The tariff actions enacted in the United States during 2025 have introduced measurable frictions across pharmaceutical supply chains, and enflurane has not been immune to these effects. Tariffs influence not only unit cost structures but also sourcing strategies, contractual relationships, and inventory policies. In response, many downstream stakeholders have revisited supplier diversity and nearshoring options to mitigate exposure to tariffs and the volatility they can introduce into procurement cycles. These adaptive behaviors, in turn, change how providers approach stocking depth and lead-time buffers for anesthesia agents.

Beyond procurement, tariff-induced changes have prompted manufacturers and distributors to reassess pricing strategies and distribution footprints. Some producers have explored reconfiguration of manufacturing logistics to preserve competitiveness, while others have adjusted contractual terms with intermediate distributors to protect margins. For clinicians and hospital supply chain managers, these shifts have underscored the importance of anticipatory planning: formulary committees increasingly consider supplier resilience as a core criterion, and inventory governance practices have tightened to ensure uninterrupted clinical availability. Ultimately, the cumulative effect of the 2025 tariff environment is a heightened emphasis on supply-side robustness and strategic sourcing that directly affect enflurane accessibility and institutional preparedness.

Comprehensive segmentation insights integrating end user profiles, surgical application needs, product type distinctions, and distribution channel dynamics to clarify demand determinants

A granular view of demand and operational considerations emerges when enflurane is analyzed through established segmentation lenses, each of which reveals distinct drivers and constraints. When examined by end user, differences in procedural volume, staffing models, and formulary governance mean that ambulatory surgery centers, clinics, and hospitals exhibit divergent preferences for anesthetic agents; ambulatory settings often prioritize rapid recovery and throughput, clinics may emphasize cost-effective protocols for minor procedures, and hospitals must balance a broader range of surgical complexity with institutional risk policies.

Looking across application areas such as cardiovascular surgery, general surgery, neurosurgery, and orthopedic surgery, the clinical imperatives that inform agent selection vary substantially. Cardiovascular procedures demand strict hemodynamic control and multispecialty coordination, neurosurgery raises unique concerns about cerebral physiology and seizure thresholds, orthopedic surgery frequently focuses on multimodal analgesia and efficiency, and general surgery encompasses a wide clinical spectrum that necessitates flexible anesthetic strategies. Product-type segmentation further complicates decision-making: the presence of branded and generic options influences procurement negotiations, perceived interchangeability, and regulatory documentation, while perceptions about manufacturing quality and supply reliability can drive preference for one product type over another. Distribution channel dynamics shape availability and access; direct sales relationships support tailored service models for large health systems, online channels including B2B portals and e-commerce platforms enable broader commercial reach, retail pharmacy pathways structured around chain and independent pharmacies affect outpatient accessibility, and wholesale distribution remains a backbone for large-scale replenishment. Interactions among these segments determine both the operational realities of supplying enflurane and the clinical contexts in which it is likely to be used.

High-resolution regional analysis comparing Americas, Europe Middle East & Africa, and Asia-Pacific differences in clinical adoption, supply resilience, and regulatory environments

Regional dynamics play a defining role in enflurane's clinical relevance, supply arrangements, and regulatory environment, with distinct patterns observable across major geographies. In the Americas, institutional procurement practices, reimbursement frameworks, and a concentration of large integrated health systems often lead to standardized formulary governance and centralized contracting, influencing which anesthetic agents are maintained on hospital shelves and how quickly alternative sourcing can be enacted when disruptions occur. Regulatory oversight in this region emphasizes post-market surveillance and clinician safety, shaping the conditions under which enflurane is selected.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory regimes, healthcare infrastructure maturity, and procurement modalities vary widely between and within countries. In several Western European jurisdictions, strong environmental and sustainability mandates exert a material influence on anesthetic agent policy, while in parts of the Middle East and Africa, access and supply chain resilience remain primary operational concerns. Finally, Asia-Pacific dynamics reflect rapid healthcare capacity expansion, a diverse mix of public and private service delivery models, and strategic investments in manufacturing and supply chain localization. This region also exhibits differing clinical practice norms and regulatory tempos, which together determine how enflurane is evaluated, adopted, and distributed across facilities.

Company-level competitive insights emphasizing supply strategies, portfolio optimization, quality transparency, and clinician engagement approaches among enflurane stakeholders

Competitive positioning among companies involved with enflurane spans legacy producers, specialty pharmaceutical manufacturers, distributors, and clinical services providers. Several organizations have focused on portfolio rationalization and operational efficiency to maintain supply continuity for older anesthetic agents, while others have prioritized investments in regulatory compliance and quality control to support long-term contracting with health systems. Distinct strategies have emerged: some firms emphasize vertical integration of manufacturing and distribution to reduce exposure to intermediated disruptions, whereas others cultivate diversified supplier networks to achieve resilience.

Innovation efforts in the sector are often concentrated on formulation consistency, packaging improvements that enhance handling and dosing accuracy, and collaborations with device makers to improve delivery and scavenging. Additionally, companies that proactively engage with clinicians through evidence dissemination, training programs, and formulary support tend to secure stronger institutional adoption and long-term contractual relationships. Across the value chain, transparency about manufacturing provenance, lot-level traceability, and responsiveness to quality inquiries has become a differentiator that influences purchasing decisions, particularly among large hospital systems and purchasing consortia.

Actionable recommendations for manufacturers, distributors, and healthcare providers to fortify supply resilience, engage clinicians, incorporate sustainability, and optimize distribution strategies

Industry leaders seeking to position themselves effectively in the evolving enflurane landscape should adopt a set of pragmatic, actionable measures that align commercial, clinical, and operational priorities. First, prioritize supplier resilience by diversifying sourcing and negotiating contractual mechanisms that provide supply guarantees and flexibility to adjust volume commitments in response to demand variability. Second, engage proactively with clinical stakeholders by funding targeted education and evidence reviews that clarify enflurane's comparative benefits and risk management protocols for specific surgical applications. These clinician-facing efforts will build trust and facilitate constructive formulary discussions.

Third, incorporate environmental impact considerations into product value propositions by documenting life-cycle footprints and supporting investments in scavenging and destruction technologies where applicable. Fourth, strengthen quality and traceability capabilities: transparent manufacturing data and lot-level documentation reduce procurement friction and support regulatory compliance. Fifth, reassess distribution strategies to include a mix of direct sales for key accounts and robust online and wholesale partnerships to preserve access across diverse care settings. Finally, maintain active regulatory engagement to anticipate policy shifts and to participate in guideline development, thereby influencing the terms under which enflurane is evaluated by decision-makers.

Robust research methodology describing evidence triangulation, expert validation, qualitative synthesis, and scenario-based stress testing used to underpin the enflurane analysis

This analysis synthesizes multiple evidence streams using a structured methodology that emphasizes source triangulation, expert validation, and contextual interpretation. Primary inputs include peer-reviewed clinical literature, regulatory guidance documents, and anonymized supply chain intelligence drawn from procurement practitioners and manufacturing stakeholders. Secondary inputs encompass white papers, technical guidance on anesthesia delivery and scavenging, and operational case studies from institutions that have evaluated enflurane within formulary decision processes.

To ensure robustness, qualitative insights from clinician interviews and supply chain managers were cross-referenced with regulatory documents and manufacturing quality information. Analytical steps included thematic coding of qualitative data, scenario mapping to explore implications of policy and procurement shifts, and stress-testing of supply chain assumptions against documented tariff and logistics changes. Findings were validated through expert review panels comprising anesthesiologists, pharmacists, and procurement leaders to confirm practical relevance and to refine recommendations. Throughout the process, transparency about assumptions and evidence sources was maintained to support reproducibility and to facilitate client-specific customization during post-report advisory engagements.

Concluding synthesis of strategic implications for manufacturers, healthcare providers, and policymakers aimed at ensuring defensible, patient-centered, and operationally resilient decisions about enflurane

In conclusion, enflurane occupies a nuanced position in contemporary anesthesia practice: while its routine use has declined in many settings, it retains potential utility where specific pharmacologic attributes align with clinical needs. The convergence of regulatory attention, sustainability concerns, and supply chain pressures has redefined the criteria by which anesthetic agents are selected and maintained on formularies. Consequently, stakeholders must balance clinical efficacy with considerations of supply resilience, environmental footprint, and institutional risk tolerance.

Moving forward, strategic attention to supplier diversification, clinician engagement, and transparent quality practices will determine how enflurane figures into perioperative care pathways. Policymakers and institutional leaders should prioritize evidence-informed guideline development and procurement policies that incorporate operational realities and environmental considerations. By aligning clinical protocols, procurement strategies, and regulatory dialogue, stakeholders can ensure that decisions about enflurane are defensible, patient-centered, and operationally sustainable.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Spate of regulatory reviews assessing environmental impact of enflurane emissions
  • 5.2. Growing interest in enflurane formulations tailored for low-resource surgery centers
  • 5.3. Integration of new closed-circuit anesthetic delivery systems to reduce enflurane consumption
  • 5.4. Emerging partnerships between generic manufacturers and OEM suppliers to expand enflurane access in Asia
  • 5.5. Clinical research exploring enflurane use in outpatient oncology sedation and pain management protocols
  • 5.6. Accelerated price competition from alternative fluorinated anesthetics challenging enflurane market share in Europe

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enflurane Market, by End User

  • 8.1. Ambulatory Surgery Centers
  • 8.2. Clinics
  • 8.3. Hospitals

9. Enflurane Market, by Application

  • 9.1. Cardiovascular Surgery
  • 9.2. General Surgery
  • 9.3. Neurosurgery
  • 9.4. Orthopedic Surgery

10. Enflurane Market, by Product Type

  • 10.1. Branded
  • 10.2. Generic

11. Enflurane Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online
    • 11.2.1. B2B Portals
    • 11.2.2. E-Commerce Platforms
  • 11.3. Retail Pharmacy
    • 11.3.1. Chain Pharmacy
    • 11.3.2. Independent Pharmacy
  • 11.4. Wholesale

12. Enflurane Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enflurane Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enflurane Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Fresenius Kabi AG
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. Piramal Enterprises Limited
    • 15.3.5. Hikma Pharmaceuticals PLC
    • 15.3.6. Baxter International Inc.
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
    • 15.3.8. Sandoz International GmbH
    • 15.3.9. Viatris Inc.
    • 15.3.10. Hetero Labs Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENFLURANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 249. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GCC ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. GCC ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. GCC ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. GCC ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. GCC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. GCC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. GCC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. GCC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. GCC ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 260. GCC ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 261. GCC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 291. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. G7 ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. G7 ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. G7 ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. G7 ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. G7 ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. G7 ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. G7 ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 300. G7 ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 301. G7 ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 302. G7 ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 303. G7 ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 305. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. NATO ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. NATO ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. NATO ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NATO ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. NATO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. NATO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. NATO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. NATO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. NATO ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 316. NATO ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 317. NATO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 318. NATO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED STATES ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED STATES ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED STATES ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED STATES ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED STATES ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED STATES ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED STATES ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 333. CANADA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. CANADA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. CANADA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. CANADA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. CANADA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. CANADA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. CANADA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 340. CANADA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 341. CANADA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 342. CANADA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 343. CANADA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 344. CANADA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 345. MEXICO ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. MEXICO ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 347. MEXICO ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. MEXICO ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. MEXICO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. MEXICO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. MEXICO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 352. MEXICO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 353. MEXICO ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 354. MEXICO ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 355. MEXICO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 356. MEXICO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 357. BRAZIL ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. BRAZIL ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. BRAZIL ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 360. BRAZIL ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 361. BRAZIL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. BRAZIL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 363. BRAZIL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 364. BRAZIL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 365. BRAZIL ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 366. BRAZIL ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 367. BRAZIL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 368. BRAZIL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 369. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 370. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 371. UNITED KINGDOM ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 372. UNITED KINGDOM ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 373. UNITED KINGDOM ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. UNITED KINGDOM ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 375. UNITED KINGDOM ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 376. UNITED KINGDOM ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 377. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 378. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 379. UNITED KINGDOM ENFLURANE MARKET SIZE, BY RE